BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 14499791)

  • 1. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Fishbein G; Hyslop T; Hauck WW; Kutch M; Grana JR; Schlackman N
    Cancer Detect Prev; 2001; 25(2):174-82. PubMed ID: 11341353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
    Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
    Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.
    Schroy PC; Geller AC; Crosier Wood M; Page M; Sutherland L; Holm LJ; Heeren T
    Prev Med; 2001 Nov; 33(5):381-91. PubMed ID: 11676578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting.
    Dulai GS; Farmer MM; Ganz PA; Bernaards CA; Qi K; Dietrich AJ; Bastani R; Belman MJ; Kahn KL
    Cancer; 2004 May; 100(9):1843-52. PubMed ID: 15112264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of self-reported history of colorectal cancer screening.
    Khoja S; McGregor SE; Hilsden RJ
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preferences for colorectal cancer screening.
    Leard LE; Savides TJ; Ganiats TG
    J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer on the front line.
    Lemon SC; Zapka JG; Estabrook B; Erban S; Luckmann R
    Am J Gastroenterol; 2003 Apr; 98(4):915-23. PubMed ID: 12738477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening: physician attitudes and practices.
    Taylor ML; Anderson R
    WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.
    Rossi F; Sosa JA; Aslanian HR
    J Clin Gastroenterol; 2008; 42(10):1089-94. PubMed ID: 18936643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening by primary care physicians in two medical care organizations.
    Hawley ST; Levin B; Vernon SW
    Cancer Detect Prev; 2001; 25(3):309-18. PubMed ID: 11425273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
    Seeff LC; Shapiro JA; Nadel MR
    J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening.
    Myers RE; Turner B; Weinberg D; Hyslop T; Hauck WW; Brigham T; Rothermel T; Grana J; Schlackman N
    Prev Med; 2004 Apr; 38(4):375-81. PubMed ID: 15020170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.
    Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W
    Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT.
    Clavarino AM; Janda M; Hughes KL; Del Mar C; Tong S; Stanton WR; Aitken JF; Leggett BA; Newman B
    Prev Med; 2004 Sep; 39(3):482-90. PubMed ID: 15313087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.